EV/EBITDA:
-1.16+0.08(+6.45%)Summary
- As of today, MLTX EV/EBITDA is -1.16, with a rise of +0.08 (+6.45%) during the most recent trading session on October 17, 2025.
- Over the past year, MLTX EV/EBITDA has increased by +22.27 (+95.05%).
- MLTX EV/EBITDA is now -383.33% below its all-time high of -0.24.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +6.5% | -6.7% | -2.8% |
| 1M1 Month | +92.1% | -92.1% | -82.2% |
| 3M3 Months | +92.5% | -92.6% | -83.2% |
| 6M6 Months | +90.3% | -88.7% | -76.2% |
| YTDYTD | +94.5% | -92.3% | -83.2% |
| 1Y1 Year | +95.0% | -91.0% | -81.0% |
| 5Y5 Years | - | - | - |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -0.24 | -383.3% | -18.08 | +93.6% |
| 3M | 3-Month | -0.24 | -383.3% | -18.08 | +93.6% |
| 6M | 6-Month | -0.24 | -383.3% | -18.08 | +93.6% |
| 1Y | 1-Year | -0.24 | -383.3% | -28.21 | +95.9% |
| 3Y | 3-Year | -0.24 | -383.3% | -61.99 | +98.1% |
| 5Y | 5-Year | -0.24 | -383.3% | -1492 | +99.9% |
| All-Time | All-Time | -0.24 | -383.3% | -1492 | +99.9% |
MLTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.16(+94.5%) |
| 2024 | -20.96(+63.9%) |
| 2023 | -58.11(-1019.7%) |
| Date | Value |
|---|---|
| 2022 | -5.19(-121.8%) |
| 2021 | -2.34(+99.8%) |
| 2020 | -1333.00 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -1.16
What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -0.24
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +19.80 (+94.47%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +22.27 (+95.05%)